glutathione synthetase cofactor Glutathione-Dependent Pathways in Cancer Cells and intestinal tract Glutathione Participation in the Prevention
Description
Higuchi Y., Kawakami S., Hashida M., BioDrugs 2010, 24, 195
2017;9:a022129
Protection against fatty liver disease Animal studies show that UGT1A1 variants that increase bilirubin also decrease the risk and severity of fatty liver disease (NAFLD)
The lack of evidence may also be an issue of strengthening protocol
